Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1975 May 17;2(5967):363–365. doi: 10.1136/bmj.2.5967.363

Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.

C Christiansen, P Rodbro, O Munck
PMCID: PMC1673157  PMID: 165857

Abstract

In 54 epileptic outpatients treated for at least one year with anticonvulsants the bone mineral content (B.M.C.), an estimate of total body calcium, and serum calcium were measured before and during treatment with three doses of cholecalciferol (vitamin D3; 200, 100, and 50 mu-g daily) and 25-hydroxycholecalciferol (25-OHD3; 40, 20, and 10 mu-g daily) for 12 weeks. The results, when compared with the effects of calciferol (vitamin D2; 200, 100, and 50 mu-g daily) in 40 epileptic outpatients, showed different actions in anticonvulsant osteomalacia of vitamin D2 on the one hand and vitamin D3 and 25-OHD3 on the other. In the patients who received vitamin D2 an increase in B.M.C. was found whereas serum calcium was unchanged. The patients who received vitamin D3 or 25-OHD3 showed an increase in serum calcium but unchanged values of B.M.C. The results suggest that liver enzyme induction cannot alone explain anticonvulsant osteomalacia.

Full text

PDF
364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger G., Munde B. Knochenstrukturveränderungen bei antikonvulsiver Langzeitbehandlung. Dtsch Gesundheitsw. 1970 Aug 13;25(33):1549–1551. [PubMed] [Google Scholar]
  2. Christiansen C., Nielsen S. P., Rodbro P. Letter: Anticonvulsant hypomagnesaemia. Br Med J. 1974 Feb 2;1(5900):198–199. doi: 10.1136/bmj.1.5900.198-e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christiansen C., Rodbro P. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia. Acta Neurol Scand. 1974;50(5):631–641. doi: 10.1111/j.1600-0404.1974.tb02808.x. [DOI] [PubMed] [Google Scholar]
  4. Christiansen C., Rodbro P., Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J. 1973 Dec 22;4(5894):695–701. doi: 10.1136/bmj.4.5894.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohn S. H., Ellis K. J., Wallach S., Zanzi I., Atkins H. L., Aloia J. F. Absolute and relative deficit in total-skeletal calcium and radial bone mineral in osteoporosis. J Nucl Med. 1974 Jun;15(6):428–435. [PubMed] [Google Scholar]
  6. DeLuca H. F. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone. N Engl J Med. 1973 Aug 16;289(7):359–365. doi: 10.1056/NEJM197308162890710. [DOI] [PubMed] [Google Scholar]
  7. Dent C. E., Richens A., Rowe D. J., Stamp T. C. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970 Oct 10;4(5727):69–72. doi: 10.1136/bmj.4.5727.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hahn T. J., Birge S. J., Scharp C. R., Avioli L. V. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest. 1972 Apr;51(4):741–748. doi: 10.1172/JCI106868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hahn T. J., Hendin B. A., Scharp C. R., Haddad J. G., Jr Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med. 1972 Nov 2;287(18):900–904. doi: 10.1056/NEJM197211022871803. [DOI] [PubMed] [Google Scholar]
  10. Lifshitz F., Maclaren N. K. Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr. 1973 Oct;83(4):612–620. doi: 10.1016/s0022-3476(73)80223-9. [DOI] [PubMed] [Google Scholar]
  11. Linde J., Hansen J. M., Siersbaek-Nielsen K., Fuglsang-Frederiksen V. Vitamin D in patients on anticonvulsants. Br Med J. 1972 Dec 2;4(5839):547–547. doi: 10.1136/bmj.4.5839.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Omdahl J. L., DeLuca H. F. Regulation of vitamin D metabolism and function. Physiol Rev. 1973 Apr;53(2):327–372. doi: 10.1152/physrev.1973.53.2.327. [DOI] [PubMed] [Google Scholar]
  13. Richens A., Rowe D. J. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–76. doi: 10.1136/bmj.4.5727.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rowe D. J., Stamp T. C. Letter: Anticonvulsant osteomalacia and vitamin D. Br Med J. 1974 Mar 2;1(5904):392–392. doi: 10.1136/bmj.1.5904.392-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sotaniemi E. A., Hakkarainen H. K., Puranen J. A., Lahti R. O. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy. Ann Intern Med. 1972 Sep;77(3):389–394. doi: 10.7326/0003-4819-77-3-389. [DOI] [PubMed] [Google Scholar]
  16. Stamp T. C., Round J. M., Rowe D. J., Haddad J. G. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J. 1972 Oct 7;4(5831):9–12. doi: 10.1136/bmj.4.5831.9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES